Treatment of Tuberculosis: guidelines for national programmes from WHO - book or pamphlet about TB

Treatment of Tuberculosis: guidelines for national programmes

Here is a book or pamphlet about TB :





















Treatment of Tuberculosis: guidelines for national programmes
4th edition - English only : English [pdf 1Mb] , Buy a hard copy


Contents
1. Introduction 15
1.1 Chapter objectives 15
1.2 Purpose of the guidelines 15
1.3 Target audience 15
1.4 Scope
1.5 Why a new edition? 15
1.6 Methodology 18
1.7 I International Standards for Tuberculosis Care 21
1.8 E Expiry date 21
2. Case definitions 23
2.1 Chapter objectives 23
2.2 Purposes of defining a TB case 23
2.3 Case definitions 23
2.4 Anatomical site of TB disease 24
2.5 Bacteriological results 25
2.6 History of previous treatment: patient registration group 26
2.7 HIV status 28
3. Standard treatment regimens 29
3.1 Chapter objectives 29
3.2 Aims of treatment 29
3.3 E Essential anti-TB drugs 29
3.4 S Standard regimens for defined patient groups 31
3.5 N New patients 32
3.6 Previously treated patients and multidrug resistance 36
3.7 S Standard regimens for previously treated patients 38
3.8 Overall considerations in selecting a country’s standard regimens 42
57
4.6 Cohort analysis of treatment outcomes 57
4.7 Management of treatment interruption 59
4.8 Prevention of adverse effects of drugs 59
4.9 Monitoring and recording adverse effects 60
4.10 S Symptom-based approach to managing side-effects of anti-TB drugs 60
5. Co-management of HIV and active TB disease 65
5.1 Chapter objectives 65
5.2 HIV testing and counselling for all patients known or suspected to have TB 65
5.3 HIV prevention in TB patients 67
5.4 TB treatment in people living with HIV 67
5.5 Co-trimoxazole preventive therapy 69
5.6 Antiretroviral therapy 69
5.7 D Drug susceptibility testing 71
5.8 Patient monitoring during TB treatment 71
5.9 Considerations when TB is diagnosed in people living with HIV who are
already receiving antiretroviral therapy 72
5.10 HIV-related prevention, treatment, care and support 72
6. Supervision and patient support 75
6.1 Chapter objectives 75
6.2 Roles of the patient, TB programme staff, the community and other providers 75
6.3 S Supervised treatment 77
6.4 U Using a patient-centred approach to care and treatment delivery 78
6.5 Prevention of treatment interruption 80
7. Treatment of drug-resistant tuberculosis 83
7.1 Chapter objectives 83
7.2 Green Light Committee Initiative 83
7.3 Groups of drugs to treat MDR-TB 84
7.4 General principles in designing an MDR-TB treatment regimen 86
7.5 Programmatic strategies for treatment of MDR-TB 86
7.6 S Selection of the country’s standard MDR-TB treatment regimen 89
7.7 S Selection of individualized MDR-TB regimens 89
7.8 Monitoring the MDR-TB patient 91
7.9 D Duration of treatment for MDR-TB 91
7.10 Treating TB with resistance patterns other than MDR 92
7.11 Recording and reporting drug-resistant TB cases, evaluation of outcomes 92
8. Treatment of extrapulmonary TB and of TB in special situations 95
8.1 Chapter objectives 95
8.2 Treatment of extrapulmonary TB 95
8.3 I Important drug interactions 96
8.4 Treatment regimens in special situations 97
A
nnexes 101
1. E Essential first-line antituberculosis drugs 103
2. S Summary of evidence and considerations underlying the recommendations 115
3. TB treatment outcomes 131
4. I Implementation and evaluation of the fourth edition 133
5. S Suggestions for future research 141
6. Members of the Guidelines Group 145